SPECTRAMED, INC. – Trademark Portfolio
Entity Type: 03
SPECTRAMED, INC. holds 26 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 21 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 4 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include CRITIKIT, R.O.S.E., and CRITICATH. The owner is based in OXNARD, CA.
1900 WILLIAMS DRIVE
OXNARD, CA 93030
Showing of trademarks Trademarks
Trademark Classifications
SPECTRAMED, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does SPECTRAMED, INC. have?
SPECTRAMED, INC. has 26 U.S. trademarks filed with the USPTO. Of these, 3 registered, 3 abandoned, 20 cancelled.
What trademark classes does SPECTRAMED, INC. file in?
SPECTRAMED, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are SPECTRAMED, INC.'s most well-known trademarks?
SPECTRAMED, INC.'s registered trademark portfolio includes well-known marks such as CRITIKIT, R.O.S.E., and CRITICATH. These are among 3 currently registered trademarks in the portfolio.
What is SPECTRAMED, INC.'s trademark registration success rate?
SPECTRAMED, INC. has a 12% trademark registration rate, with 3 out of 26 resolved applications resulting in successful registration. Currently, 0 applications are pending review.